	Clinical utility of molecular residual disease detection in early-stage resected EGFR-mutated non-small cell lung cancer. Nat Commun Zhou F, Su C, Liang W, Xu LD, Tao W, Qian J, Xu S, Liu D, Fan R, Zhang Y, Liu Y, Wu L, Fu X, Zhang X, Shen N, Ge D, Chen Q, Mao W, Xu L, Chen C, Hu B, Shao G, Hu J, Zhao J, Liu X, Liu Z, Wang Z, Xiao Z, Gong T, Lin W, Li X, Ye F, Liu Y, Ma H, Huang Y, Zhou J, Wang Z, Fu J, Ding L, Mao L, Chen W, He J, Zhou C. PMID: 42706268 [PubMed - indexed for MEDLINE]
	Unraveling lung cancer complexity: Spatial omics in tumor microenvironment characterization and precision medicine. Curr Probl Cancer Dasgupta S, Das S, Saha S. PMID: 42705130 [PubMed - as supplied by publisher]
	Efficacy and Safety of Savolitinib Plus Osimertinib in EGFR-Mutant, MET-Aberrant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Am J Clin Oncol Amir E, Khan MW, Mannan MS, Rayyan SM, Khan MAH, Saif H, Shahbaz H, Hussain SM, Khan H, Shahzaib M, Iqbal M, Javed A. PMID: 42704725 [PubMed - as supplied by publisher]
	Robot-assisted thoracoscopic fissureless fissure-last approach versus conventional interlobar method for left lower lobectomy in lung cancer: a comparative study of short-term outcomes. Gen Thorac Cardiovasc Surg Miyamoto T, Matsui S, Fujiwara W, Kidokoro Y, Kubouchi Y, Miwa K, Nakamura H, Tanaka Y. PMID: 42704591 [PubMed - as supplied by publisher]
	Prognostic Impact of Lymphovascular Invasion in Resected Pathological Stage I Invasive Non-small Cell Lung Cancer: A Propensity Score-Matched Cohort Study. Ann Surg Oncol Man L, Hao X, Zhang X, Cheng J, Xia L, Guo M, Xie Y, Cui R, Zhou W, Liu L. PMID: 42704565 [PubMed - as supplied by publisher]
	Artificial intelligence for lung cancer classification in cytology specimens: A systematic review and diagnostic test accuracy meta-analysis of benign-malignant diagnosis and ADC/SCC/SCLC subtyping. J Pathol Inform Myssayev A, Tamadon A, Mussin NM, Shirazi R, Zare A. PMID: 42703599 [PubMed]
	Ivonescimab Plus Chemotherapy versus Bevacizumab Plus Chemotherapy in EGFR-Mutant Lung Adenocarcinoma After EGFR-TKI Failure: A Two-Center Retrospective Real-World Propensity Score-Matched Study. Drug Des Devel Ther Zhou J, Wang Y, Wen K, Huang C, Huang D, Qin T, Li M, Su Y, Sun Y, Chen P. PMID: 42703567 [PubMed - indexed for MEDLINE]
	Bronchial Artery Chemoembolization (BACE) Combined with PD-1 Blockade Versus Chemotherapy Combined with PD-1 Blockade for Non-Small Cell Lung Cancer in Older Adults. Clin Interv Aging Xiang J, Tu J, Gong W, Chen P, Wang Y, Li W, Zhong J, Ji J, Huang J. PMID: 42703541 [PubMed - indexed for MEDLINE]
	Lung Cancer Screening-Eligible Population From 2000 to 2050 in Argentina: A Simulation Study Brief Report. JTO Clin Res Rep Salgado MV, Jeon J, Cao P, Boyeras I, Mejia R, Meza R. PMID: 42703497 [PubMed]
	Coeliac lymph nodes SBRT Combined with Immunotherapy Rechallenge Induce Abscopal Effect in Metastatic Non-Small-Cell Lung Cancer: A Case Report and Literature Review. J Pak Med Assoc Yan J, Guo Y, Zhao W, Zhang X, Yang Y, Tang X. PMID: 42703131 [PubMed - indexed for MEDLINE]
	TNF-α-Mediated Molecular Switching Links COPD to Lung Cancer: Integrated In Silico and In Vivo Study of Oxidative Stress-Driven Disease Transition. Pulm Pharmacol Ther Manna R, Das J, Roy D, Bhattacharya S, Saha S, Sur R, Chatterjee IB, Banerjee R. PMID: 42702300 [PubMed - as supplied by publisher]
	Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial. Lancet Daly ME, Simone CB 2nd, Redman MW, Hsieh MH, Hesketh PJ, Hu C, Monjazeb AM, Steuer CE, Ganti AK, Kashani R, Bauman JR, Feliciano JL, Moon J, Ku K, Le-Lindqwister N, Baschnagel AM, Maraboyina S, Sherwood GB, Almquist D, Higgins KA, Gray JE, Bradley JD, Kelly K. PMID: 42702214 [PubMed - as supplied by publisher]
	The changing therapeutic landscape of small-cell lung cancer. Lancet Ross JS, Hockemeyer KG, Redin E, Rudin CM. PMID: 42702213 [PubMed - as supplied by publisher]
	Targeted therapies in advanced non-small-cell lung cancer: new biomarkers and treatment strategies. Lancet Respir Med Hendriks LEL, Lin JJ, Tan DSW, Acker F, Ogliari FR, Meyer ML, Planchard D, Reck M. PMID: 42702211 [PubMed - as supplied by publisher]
	Early-stage non-small-cell lung cancer: emerging treatments and evolving challenges. Lancet Respir Med Remon J, Cascone T, Saw SPL, Frost N, Li MSC, Hendriks LEL, Levy A, Federico AD, Chaft JE, Abdelhamid K, Awad M, Mountzios G, Peters S. PMID: 42702210 [PubMed - as supplied by publisher]
	Congenital pulmonary airway malformation mimicking lung cancer in adults: a pitfall in oncologic diagnosis. Quant Imaging Med Surg Tian F, Xu Q, Chen J, Huang A, Zhao B, Qi C, Hu H, Wang J. PMID: 42701588 [PubMed]
	Spectral computed tomography multi-parameter images for differentiating between tumor tissue and inflammatory tissue in pneumonic-type lung carcinoma lesions. Quant Imaging Med Surg Ma YQ, Zheng YK, Han QX, Zhang XY, Huang G, Wang LL, Jiao ZM. PMID: 42701536 [PubMed]
	Impact of CT slice thickness reduction algorithm on AI-based lung nodule detection in chest CTs of colorectal cancer patients. Quant Imaging Med Surg Kang SR, Jeong WG, Rho JY, Choi H, Kim YH, Lee JH, Jin GY. PMID: 42701524 [PubMed]
	Integrating molecular subtypes, genomics and functional dependencies to identify context-specific therapeutic vulnerabilities in small cell lung cancer. Biomark Res Cassotti I, Fiume V, Gandellini P, Storlazzi CT. PMID: 42701198 [PubMed]
	Corrigendum to "The safety of extended dosing pembrolizumab when compared to traditional dosing: a review and meta-analysis of retrospective studies" [Lung Cancer 204 (2025) 108585]. Lung Cancer Sekar P, Kumar AA, Hughes I, Mason R, Dzienis M. PMID: 42701067 [PubMed - as supplied by publisher]

Articles 1 - 20 / 161836

Page 1 of 8092



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy